2morrow, a digital health startup that developed a clinically validated smoking cessation app to support a six month program, forged a partnership with GlaxoSmithKkine to improve access to its nicotine replacement therapy.
SmartQuit users who are using the app as part of an employer program will receive nicotine replacement therapy as part of their regimen.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Photo: Flickr user Qfamily